Posts

3D digital technologies tackling mental injury preventi...

The Safety Sensescaping project, funded by WorkSafe’s WorkWell Mental Health Imp...

Concentration of cell membrane components with nanocarb...

Overview Credit: COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RE...

New theory developed for periodically driven quantum do...

A team led by Prof. GUO Guoping and Prof. CAO Gang from the University of Scienc...

Acumen’s Next-Gen Leqembi Rival Shows Promise in Early ...

Acumen Pharmaceuticals recently unveiled early clinical evidence showcasing the ...

Antengene’s multiple myeloma therapy receives approval ...

Antengene has received approval in Hong Kong for a new drug application (NDA) fo...

Vivoryon issues updates on its Alzheimer’s therapy prog...

The complete data readouts of two-Phase II trials are expected in 2024, with an ...

Korro Bio enters merger deal with Frequency Therapeutics

Korro Bio has signed a definitive merger agreement with Frequency Therapeutics t...

Lilly to acquire biopharma firm Versanis for $1.9bn

Eli Lilly and Company has signed an agreement for the acquisition of biopharmace...

Fighting AMR with a value and subscription model 

The recent reintroduction of the Pasteur Act seeks to address the global threat ...

Futura Medical and Haleon partner to commercialise Erox...

UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC e...

FDA expands Veklury’s use to Covid-19 patients with sev...

The move follows a positive decision made by the EMA earlier this year, broadeni...

Eleven and Novo Nordisk partner to develop nucleic acid...

The companies will develop new molecules using Eleven's innovative DELiveri plat...

SNIPR celebrates US court’s favourable ruling on CRISPR...

The US Federal Court overturned a previous ruling in the patent infringement cas...

Australian CAI unveils new facility for cancer therapy ...

The Centre for Advanced Imaging (CAI) of the University of Queensland in Austral...

Researchers turn to CRISPR to unlock one of the trickie...

Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alz...

STAT+: After FDA nod, Better Therapeutics races to boos...

In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...